Mifepristone attenuates depression-like changes induced by chronic central administration of interleukin-1β in rats
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
HighlightsIL‐1&bgr; increased the levels of pro‐BDNF, but decreased GDNF and GFR&agr;1 in the amygdale.RU486 improved the depression‐like behaviors induced by IL‐1&bgr;.RU486 differently regulated the function of microglia and astrocyte. ABSTRACT Increased proinflammatory cytokines, such as interleukin (IL)‐1&bgr;, may play an important role in the etiology of depression because they cause the hypothalamic–pituitary–adrenal axis to release glucocorticoids (GC) and induce dysfunction of serotonin and norepinephrine neurotransmission. Sustained increase in GC may activate microglia to induce neuroinflammation, and suppress astrocytes to produce neurotrophins, which lead to neuronal apoptosis. Here, we tested the hypothesis that glucocorticoid receptor (GR) antagonist mifepristone (RU486) may attenuate IL‐1&bgr;‐induced depression‐like behavior by regulating the neuroinflammation and neurotrophin functions of microglia and astrocytes. Rats received intracerebroventricular injections of IL‐1&bgr; (10 ng) and/or subcutaneous injections of RU486 for 14 days. Then animal depression‐like behaviors, serum corticosterone concentration, the levels of pro‐inflammatory cytokines (TNF‐&agr;, IL‐6), mRNA and protein expressions of CD11b, GFAP and neurotrophins (pro‐BDNF, BDNF, GDNF and their receptors TrkB, p75, GFR&agr;‐1 and GFR&agr;‐2) in the amygdala were studied. Compared to controls, significantly decreased rearing score and increased defecation in the open field test, decreases in ratio of open/closed time in the elevated plus maze and in sucrose preference, while increased level of corticosterone in the serum were found in the rats administrated with IL‐1&bgr;. IL‐1&bgr; administration also reduced the expressions of GFAP, BDNF, GDNF and its receptor GFR‐&agr;1, but increased the expressions of CD11b, pro‐BDNF, p75 and pro‐inflammatory cytokines (TNF‐&agr;, IL‐6) concentrations. RU486 treatment markedly attenuated these changes induced by IL‐1&bgr;, except for the expressions of GFR‐&agr;1. In conclusion, RU486 may improve depression‐like changes by suppressing microglia and inflammation and promoting astrocytes to restore neurotrophin function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amunts, K., Kedo, O., Kindler, M., Pieperhoff, P., Mohlberg, H., Shah, N. J., Habel, U., Schneider, F., & Zilles, K. (2005) · Anatomy and Embryology · doi:10.1007/s00429-005-0025-5 · Cited by 1,264
A BDNF autocrine loop in adult sensory neurons prevents cell death
Acheson, A., Conover, J. C., Fandl, J. P., DeChiara, T. M., Russell, M., Thadani, A., Squinto, S. P., Yancopoulos, G. D., & Lindsay, R. M. (1995) · Nature · doi:10.1038/374450a0 · Cited by 765
Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Role of neurotrophic factors in depression
CASTREN, E., VOIKAR, V, & RANTAMAKI, T. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.009 · Cited by 667 · cited 1×
“Decreased GDNF expression in the hippocampus was found to contribute to depression-like behavior induced by CUMS in rats [55].”
BackgroundYoung, A. H., Gallagher, P., Watson, S., Del-Estal, D., Owen, B. M., & Nicol Ferrier, I. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300471 · Cited by 318
Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses
Frank, M. G., Thompson, B. M., Watkins, L. R., & Maier, S. F. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.10.005 · Cited by 310
Garwood, C. J., Ratcliffe, L. E., Simpson, J. E., Heath, P. R., Ince, P. G., & Wharton, S. B. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12338 · Cited by 233 · cited 1×
“Both monoamine deficiency and neurotrophin dysfunction have been raised as main contributors to the etiology of depression [42].”
BackgroundBartkowska, K., Paquin, A., Gauthier, A. S., Kaplan, D. R., & Miller, F. D. (2007) · Development · doi:10.1242/dev.008227 · Cited by 226 · cited 1×
“However, the binding of pro-BDNF to p75 receptors leads to the activation of NF-kB receptors and signal cell death via apoptosis [49].”
BackgroundClinical and Biological Effects of Mifepristone Treatment for Psychotic Depression
Flores, B. H., Kenna, H., Keller, J., Solvason, H. B., & Schatzberg, A. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300884 · Cited by 203
Castanon, N., Bluthé, R.-M., & Dantzer, R. (2001) · Psychopharmacology · doi:10.1007/s002130000595 · Cited by 136
Cited by
Cell-type-specific epigenetic effects of early life stress on the brain
Rahman, M. F., & McGowan, P. O. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02076-9 · Cited by 75
Lombardo, G., Enache, D., Gianotti, L., Schatzberg, A. F., Young, A. H., Pariante, C. M., & Mondelli, V. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104420 · Cited by 45
“Notably, the hyperproduction of glucocorticoids (GC) decreases levels of serotonin and norepinephrine available in the synaptic cleft (Zhang et al., 2018).”
BackgroundMitochondria could be a potential key mediator linking the intestinal microbiota to depression
Chen, J., & Vitetta, L. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29311 · Cited by 36
The Cytokine IL-17A as a Marker of Treatment Resistance in Major Depressive Disorder?
Nothdurfter, C., Milenkovic, V. M., Sarubin, N., Hilbert, S., Manook, A., Weigl, J., Almeqbaali, K., Wetzel, C. H., Rupprecht, R., & Baghai, T. C. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.14636 · Cited by 38
Ding, Y., Wei, Z., Yan, H., & Guo, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.732157 · Cited by 34
“The efficacy of mifepristone may also be associated with inflammation levels instead of with baseline cortisol levels given the evidence provided by a previous animal study by Zhang and colleagues (Zhang et al., 2018).”
Result
Metadata
- Authors
- Zhang, Y.-P., Wang, H.-Y., Zhang, C., Liu, B.-P., Peng, Z.-L., Li, Y.-Y., Liu, F.-M., & Song, C.
- Venue
- Behavioural Brain Research
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 347
- Pages
- 436-445
- ISSN
- 0166-4328 (ISSN-L)
- OpenAlex
- W2792716312
- Cited by
- 49
- References
- 14
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.